Anika Therapeutics, Inc. 4
4 · Anika Therapeutics, Inc. · Filed Jan 31, 2017
Insider Transaction Report
Form 4
SHERWOOD CHARLES H
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2017-01-27+125,000→ 125,000 totalExercise: $50.13Exp: 2027-01-27→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]The stock options vest in three equal annual installments beginning January 27, 2018.